MedTrace Logo

Early Goal Directed Therapy in Sepsis by Emergency Medical Services

NCT02266654 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-04-17

No results posted yet for this study

Summary

The goal is to evaluate the best way for paramedics and hospitals to work together to treat septic patients as quickly as possible.

The investigators think that the best thing to do for septic patients is to identify and treat them as early as possible. This research will test this. The investigators think that if paramedics identify septic patients and begin treatment with fluids in the ambulance, then the patient will do better in the long run. The paramedic will also tell the hospital that a septic patient will be there soon. The caregivers can prepare and be ready to provide care as soon as the patient arrives. With this research, the investigators would like to see if these steps help patient outcomes.

Conditions

Interventions

OTHER

IV fluids

Normal Saline 0.9%

OTHER

Hospital Notification

Prehospital providers will notify the receiving hospital over the radio or telephone that they are transporting a patient who meets Sepsis Criteria

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

  • Pro EMS

    collaborator UNKNOWN

  • Mount Auburn Hospital

    collaborator OTHER

Principal Investigators

  • Michael Filbin, MD · Massachusetts General Hospital

  • William Porcaro, MD, MPH · Mount Auburn Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02266654 on ClinicalTrials.gov